

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * actin-mediated cell contraction (GO:0070252) | 9.50174448 |
| 2 | skeletal muscle fiber development (GO:0048741) | 8.58442383 |
| 3 | glycogen catabolic process (GO:0005980) | 7.46548810 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.30815001 |
| 5 | myotube cell development (GO:0014904) | 7.30680525 |
| 6 | * actin filament-based movement (GO:0030048) | 7.06343247 |
| 7 | glucan catabolic process (GO:0009251) | 6.99615262 |
| 8 | creatine metabolic process (GO:0006600) | 6.87554617 |
| 9 | skeletal muscle tissue regeneration (GO:0043403) | 6.74176564 |
| 10 | purine nucleotide salvage (GO:0032261) | 6.71543577 |
| 11 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.62606954 |
| 12 | striated muscle contraction (GO:0006941) | 6.55769110 |
| 13 | cellular polysaccharide catabolic process (GO:0044247) | 6.52006758 |
| 14 | striated muscle atrophy (GO:0014891) | 6.44096320 |
| 15 | sarcomere organization (GO:0045214) | 6.43470430 |
| 16 | polysaccharide catabolic process (GO:0000272) | 6.27677674 |
| 17 | carnitine shuttle (GO:0006853) | 6.13295260 |
| 18 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 6.08924722 |
| 19 | response to muscle activity (GO:0014850) | 6.00880352 |
| 20 | plasma membrane repair (GO:0001778) | 5.93708347 |
| 21 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.85951839 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.73522450 |
| 23 | regulation of muscle hypertrophy (GO:0014743) | 5.72501026 |
| 24 | response to inactivity (GO:0014854) | 5.68914163 |
| 25 | IMP metabolic process (GO:0046040) | 5.65241918 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.61934533 |
| 27 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.61929613 |
| 28 | myofibril assembly (GO:0030239) | 5.59931640 |
| 29 | muscle atrophy (GO:0014889) | 5.58587597 |
| 30 | striated muscle adaptation (GO:0014888) | 5.50108148 |
| 31 | glycogen biosynthetic process (GO:0005978) | 5.36423974 |
| 32 | glucan biosynthetic process (GO:0009250) | 5.36423974 |
| 33 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 5.34174864 |
| 34 | cytidine metabolic process (GO:0046087) | 5.29211050 |
| 35 | cytidine catabolic process (GO:0006216) | 5.29211050 |
| 36 | cytidine deamination (GO:0009972) | 5.29211050 |
| 37 | * muscle contraction (GO:0006936) | 5.25769294 |
| 38 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.25316534 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 5.16784025 |
| 40 | muscle fiber development (GO:0048747) | 4.99889473 |
| 41 | glycogen metabolic process (GO:0005977) | 4.81493313 |
| 42 | glucan metabolic process (GO:0044042) | 4.71978763 |
| 43 | cellular glucan metabolic process (GO:0006073) | 4.71978763 |
| 44 | * muscle system process (GO:0003012) | 4.71559463 |
| 45 | protein trimerization (GO:0070206) | 4.69428887 |
| 46 | tissue regeneration (GO:0042246) | 4.69128442 |
| 47 | neuronal action potential propagation (GO:0019227) | 4.55831868 |
| 48 | carnitine transmembrane transport (GO:1902603) | 4.55190625 |
| 49 | actomyosin structure organization (GO:0031032) | 4.49543696 |
| 50 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.48791713 |
| 51 | muscle adaptation (GO:0043500) | 4.45126682 |
| 52 | IMP biosynthetic process (GO:0006188) | 4.44585915 |
| 53 | negative regulation of muscle hypertrophy (GO:0014741) | 4.38092328 |
| 54 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.35773841 |
| 55 | dosage compensation (GO:0007549) | 4.32303082 |
| 56 | cellular response to glucocorticoid stimulus (GO:0071385) | 4.30420431 |
| 57 | protein K6-linked ubiquitination (GO:0085020) | 4.27975098 |
| 58 | response to electrical stimulus (GO:0051602) | 4.21327367 |
| 59 | cellular carbohydrate catabolic process (GO:0044275) | 4.21165833 |
| 60 | carnitine transport (GO:0015879) | 4.16304966 |
| 61 | amino-acid betaine transport (GO:0015838) | 4.16304966 |
| 62 | negative regulation of organelle assembly (GO:1902116) | 4.14058898 |
| 63 | negative regulation of striated muscle tissue development (GO:0045843) | 4.12536194 |
| 64 | cellular response to ketone (GO:1901655) | 4.10187066 |
| 65 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.09149838 |
| 66 | cellular response to corticosteroid stimulus (GO:0071384) | 4.05976155 |
| 67 | neuromuscular synaptic transmission (GO:0007274) | 4.00951481 |
| 68 | cellular response to dexamethasone stimulus (GO:0071549) | 3.99264610 |
| 69 | negative regulation of muscle tissue development (GO:1901862) | 3.97457696 |
| 70 | response to testosterone (GO:0033574) | 3.90593680 |
| 71 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.89146543 |
| 72 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.88014544 |
| 73 | negative regulation of muscle organ development (GO:0048635) | 3.87505676 |
| 74 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.85184435 |
| 75 | cardiac muscle contraction (GO:0060048) | 3.75039649 |
| 76 | response to dexamethasone (GO:0071548) | 3.73126458 |
| 77 | heparin metabolic process (GO:0030202) | 3.71729930 |
| 78 | heparin biosynthetic process (GO:0030210) | 3.71729930 |
| 79 | muscle organ development (GO:0007517) | 3.71704070 |
| 80 | regulation of cofactor metabolic process (GO:0051193) | 3.69168108 |
| 81 | regulation of coenzyme metabolic process (GO:0051196) | 3.69168108 |
| 82 | muscle structure development (GO:0061061) | 3.66706503 |
| 83 | regulation of DNA methylation (GO:0044030) | 3.64004292 |
| 84 | striated muscle cell development (GO:0055002) | 3.63253967 |
| 85 | myotube differentiation (GO:0014902) | 3.59808659 |
| 86 | muscle cell cellular homeostasis (GO:0046716) | 3.58340685 |
| 87 | regulation of centriole replication (GO:0046599) | 3.55379801 |
| 88 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.50913966 |
| 89 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.48518970 |
| 90 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.47765624 |
| 91 | negative regulation of histone acetylation (GO:0035067) | 3.45552150 |
| 92 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.45473712 |
| 93 | skeletal muscle tissue development (GO:0007519) | 3.43736549 |
| 94 | cellular polysaccharide metabolic process (GO:0044264) | 3.38494824 |
| 95 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.36232827 |
| 96 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.36232827 |
| 97 | regulation of relaxation of muscle (GO:1901077) | 3.30576746 |
| 98 | regulation of striated muscle contraction (GO:0006942) | 3.30405978 |
| 99 | regulation of histone H3-K9 methylation (GO:0051570) | 3.29684064 |
| 100 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.25257127 |
| 101 | regulation of actin filament-based movement (GO:1903115) | 3.24803767 |
| 102 | myoblast fusion (GO:0007520) | 3.24537787 |
| 103 | neuromuscular junction development (GO:0007528) | 3.23776084 |
| 104 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.23759907 |
| 105 | endoplasmic reticulum organization (GO:0007029) | 3.21776108 |
| 106 | tricarboxylic acid cycle (GO:0006099) | 3.20785291 |
| 107 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.18391980 |
| 108 | * response to activity (GO:0014823) | 3.16973433 |
| 109 | negative regulation of histone methylation (GO:0031061) | 3.14856575 |
| 110 | regulation of gene expression by genetic imprinting (GO:0006349) | 3.14195662 |
| 111 | polysaccharide biosynthetic process (GO:0000271) | 3.13817626 |
| 112 | polysaccharide metabolic process (GO:0005976) | 3.13350115 |
| 113 | mitochondrial calcium ion homeostasis (GO:0051560) | 3.12009737 |
| 114 | positive regulation of myotube differentiation (GO:0010831) | 3.10997791 |
| 115 | nucleotide salvage (GO:0043173) | 3.09930163 |
| 116 | muscle cell development (GO:0055001) | 3.08962623 |
| 117 | heart process (GO:0003015) | 3.06877407 |
| 118 | heart contraction (GO:0060047) | 3.06877407 |
| 119 | intracellular lipid transport (GO:0032365) | 3.05328148 |
| 120 | positive regulation of myoblast differentiation (GO:0045663) | 3.05217603 |
| 121 | viral genome replication (GO:0019079) | 2.91261143 |
| 122 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.88946797 |
| 123 | complement activation, alternative pathway (GO:0006957) | 2.83985956 |
| 124 | regulation of muscle system process (GO:0090257) | 2.83030388 |
| 125 | regulation of skeletal muscle tissue development (GO:0048641) | 2.78962592 |
| 126 | negative regulation of protein acetylation (GO:1901984) | 2.74447956 |
| 127 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.70816090 |
| 128 | regulation of sarcomere organization (GO:0060297) | 2.70695932 |
| 129 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.63972281 |
| 130 | negative regulation of muscle contraction (GO:0045932) | 2.54965987 |
| 131 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.47612300 |
| 132 | cellular response to alcohol (GO:0097306) | 2.42682811 |
| 133 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.41723359 |
| 134 | cellular glucuronidation (GO:0052695) | 2.41423388 |
| 135 | regulation of female gonad development (GO:2000194) | 2.40206835 |
| 136 | uronic acid metabolic process (GO:0006063) | 2.39767093 |
| 137 | glucuronate metabolic process (GO:0019585) | 2.39767093 |
| 138 | relaxation of muscle (GO:0090075) | 2.39395950 |
| 139 | monocyte differentiation (GO:0030224) | 2.37214888 |
| 140 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.36153867 |
| 141 | protein localization to microtubule (GO:0035372) | 2.36111282 |
| 142 | cellular ketone body metabolic process (GO:0046950) | 2.35188727 |
| 143 | anterior/posterior axis specification, embryo (GO:0008595) | 2.34631701 |
| 144 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.34374141 |
| 145 | calcium ion import (GO:0070509) | 2.34299753 |
| 146 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.34294077 |
| 147 | regulation of muscle adaptation (GO:0043502) | 2.31257746 |
| 148 | genetic imprinting (GO:0071514) | 2.30481584 |
| 149 | response to gravity (GO:0009629) | 15.0664109 |
| 150 | regulation of skeletal muscle contraction (GO:0014819) | 13.2437043 |
| 151 | * actin-myosin filament sliding (GO:0033275) | 11.6891827 |
| 152 | * muscle filament sliding (GO:0030049) | 11.6891827 |
| 153 | skeletal muscle contraction (GO:0003009) | 11.1147884 |
| 154 | skeletal muscle adaptation (GO:0043501) | 10.9339038 |
| 155 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.3286348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.14378548 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 7.98382925 |
| 3 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 4.50453907 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 4.47708948 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.47077555 |
| 6 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.59816560 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.28191780 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.16378946 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.05518065 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.54862272 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.48663651 |
| 12 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.46416155 |
| 13 | FUS_26573619_Chip-Seq_HEK293_Human | 2.45197121 |
| 14 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.41809786 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.39097588 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.25977042 |
| 17 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.16339452 |
| 18 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.16339452 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.12630546 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.09055685 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.06192503 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.92592853 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90437624 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.87314951 |
| 25 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.87232506 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.80886316 |
| 27 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.80080679 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.78291082 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77089465 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75608421 |
| 31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.75240653 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.73565291 |
| 33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.73371339 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.72767761 |
| 35 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.72286807 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.71489323 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66484443 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.64690045 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63598440 |
| 40 | RXR_22108803_ChIP-Seq_LS180_Human | 1.60753884 |
| 41 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.59466349 |
| 42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.58149990 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.57367527 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57274754 |
| 45 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.56391076 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.51932222 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49220152 |
| 48 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.48786292 |
| 49 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.47371100 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.45562973 |
| 51 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44847669 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44340750 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44195956 |
| 54 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.43198951 |
| 55 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.41022161 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40347777 |
| 57 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.39424540 |
| 58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38087212 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37662811 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37514407 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37215985 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.36115959 |
| 63 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.34894909 |
| 64 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.33830923 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32339217 |
| 66 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.31786695 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31755968 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30158534 |
| 69 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.29627081 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28821584 |
| 71 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 1.26980342 |
| 72 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22996074 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22634983 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21444195 |
| 75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.20625275 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19433236 |
| 77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.19162554 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.17898074 |
| 79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16248662 |
| 80 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.16013935 |
| 81 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14594047 |
| 82 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14494965 |
| 83 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14118411 |
| 84 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.13638630 |
| 85 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.13318049 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12415580 |
| 87 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.12322823 |
| 88 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12032403 |
| 89 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.12015445 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11557271 |
| 91 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11095882 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10464323 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10337440 |
| 94 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10162132 |
| 95 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.10113083 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10062934 |
| 97 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09887854 |
| 98 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09887854 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09784507 |
| 100 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.09688044 |
| 101 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08554675 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08337030 |
| 103 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.07546712 |
| 104 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.07217672 |
| 105 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06478970 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06259294 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06030899 |
| 108 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.05908283 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05432441 |
| 110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05432441 |
| 111 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04330498 |
| 112 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04158280 |
| 113 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03807161 |
| 114 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.03521620 |
| 115 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.03376751 |
| 116 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02841165 |
| 117 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.02601605 |
| 118 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02544622 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02530105 |
| 120 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02424209 |
| 121 | P68_20966046_ChIP-Seq_HELA_Human | 1.01356618 |
| 122 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00120193 |
| 123 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00103034 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99298071 |
| 125 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98924042 |
| 126 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98627201 |
| 127 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97537187 |
| 128 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97051458 |
| 129 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95886671 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95856682 |
| 131 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.95740827 |
| 132 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95551114 |
| 133 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.94699407 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94580934 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94580934 |
| 136 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94443199 |
| 137 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94220102 |
| 138 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92399125 |
| 139 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91955464 |
| 140 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.91941139 |
| 141 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91859789 |
| 142 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91714782 |
| 143 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.91252657 |
| 144 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.91069990 |
| 145 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90969152 |
| 146 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.89250862 |
| 147 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89076990 |
| 148 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88995513 |
| 149 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88808190 |
| 150 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88619394 |
| 151 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.87879247 |
| 152 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87845750 |
| 153 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.87624150 |
| 154 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87594127 |
| 155 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87517891 |
| 156 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87144398 |
| 157 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86840389 |
| 158 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86787623 |
| 159 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86717855 |
| 160 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86358818 |
| 161 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85946427 |
| 162 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85489628 |
| 163 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.85113544 |
| 164 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84791277 |
| 165 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84595690 |
| 166 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.84473129 |
| 167 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84144177 |
| 168 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.83898674 |
| 169 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83602251 |
| 170 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.82898986 |
| 171 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82861501 |
| 172 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.82849971 |
| 173 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.82585735 |
| 174 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.81796780 |
| 175 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81749133 |
| 176 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81653336 |
| 177 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81580630 |
| 178 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.80821236 |
| 179 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.80149136 |
| 180 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.79498922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.42097317 |
| 2 | MP0003646_muscle_fatigue | 6.50251892 |
| 3 | MP0000749_muscle_degeneration | 6.45723842 |
| 4 | MP0000751_myopathy | 5.54235055 |
| 5 | MP0002106_abnormal_muscle_physiology | 4.35472342 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.20765538 |
| 7 | * MP0000747_muscle_weakness | 3.91037987 |
| 8 | * MP0000759_abnormal_skeletal_muscle | 3.78857029 |
| 9 | MP0005369_muscle_phenotype | 3.63727189 |
| 10 | MP0004130_abnormal_muscle_cell | 3.47274357 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 3.27314374 |
| 12 | * MP0004087_abnormal_muscle_fiber | 3.23465968 |
| 13 | * MP0002269_muscular_atrophy | 3.23042231 |
| 14 | MP0000750_abnormal_muscle_regeneration | 3.13446635 |
| 15 | * MP0005620_abnormal_muscle_contractility | 3.04567694 |
| 16 | MP0004233_abnormal_muscle_weight | 2.62441636 |
| 17 | MP0000733_abnormal_muscle_development | 2.35111506 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.23777436 |
| 19 | MP0000566_synostosis | 2.18414517 |
| 20 | MP0002108_abnormal_muscle_morphology | 2.16006973 |
| 21 | MP0001661_extended_life_span | 1.87881414 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 1.87039119 |
| 23 | MP0004185_abnormal_adipocyte_glucose | 1.86931541 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 1.74020946 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.72481841 |
| 26 | MP0005330_cardiomyopathy | 1.64768523 |
| 27 | MP0005275_abnormal_skin_tensile | 1.63317855 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.59646953 |
| 29 | MP0002971_abnormal_brown_adipose | 1.43625202 |
| 30 | MP0004270_analgesia | 1.41062970 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.40472546 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.34037839 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.28869457 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.26682205 |
| 35 | MP0000467_abnormal_esophagus_morphology | 1.19868021 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.16603091 |
| 37 | MP0002972_abnormal_cardiac_muscle | 1.11742738 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.09895734 |
| 39 | MP0003221_abnormal_cardiomyocyte_apopto | 1.07497038 |
| 40 | MP0010630_abnormal_cardiac_muscle | 1.05599003 |
| 41 | MP0008057_abnormal_DNA_replication | 1.05114027 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.03808048 |
| 43 | MP0005266_abnormal_metabolism | 1.02159506 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.01577929 |
| 45 | MP0004215_abnormal_myocardial_fiber | 1.01483284 |
| 46 | MP0004134_abnormal_chest_morphology | 1.00353161 |
| 47 | MP0004484_altered_response_of | 0.99634757 |
| 48 | MP0010307_abnormal_tumor_latency | 0.98742084 |
| 49 | MP0002796_impaired_skin_barrier | 0.93553041 |
| 50 | MP0002736_abnormal_nociception_after | 0.93507673 |
| 51 | MP0003937_abnormal_limbs/digits/tail_de | 0.92392306 |
| 52 | MP0000013_abnormal_adipose_tissue | 0.91769822 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 0.87076929 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 0.80349834 |
| 55 | MP0003385_abnormal_body_wall | 0.79401602 |
| 56 | MP0001968_abnormal_touch/_nociception | 0.78824729 |
| 57 | MP0004147_increased_porphyrin_level | 0.77177527 |
| 58 | MP0000372_irregular_coat_pigmentation | 0.76853764 |
| 59 | MP0009250_abnormal_appendicular_skeleto | 0.75802345 |
| 60 | MP0000762_abnormal_tongue_morphology | 0.75492840 |
| 61 | MP0002115_abnormal_skeleton_extremities | 0.75355733 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 0.73944633 |
| 63 | MP0005385_cardiovascular_system_phenoty | 0.73944633 |
| 64 | MP0008961_abnormal_basal_metabolism | 0.70864739 |
| 65 | MP0002234_abnormal_pharynx_morphology | 0.69761349 |
| 66 | MP0001299_abnormal_eye_distance/ | 0.69206305 |
| 67 | MP0005334_abnormal_fat_pad | 0.69011041 |
| 68 | MP0005365_abnormal_bile_salt | 0.68836298 |
| 69 | MP0003950_abnormal_plasma_membrane | 0.67853281 |
| 70 | MP0004043_abnormal_pH_regulation | 0.65939558 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.65576125 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 0.63849517 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 0.63722922 |
| 74 | MP0003868_abnormal_feces_composition | 0.63493711 |
| 75 | MP0003252_abnormal_bile_duct | 0.62360232 |
| 76 | MP0005670_abnormal_white_adipose | 0.61064207 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.60785741 |
| 78 | MP0003137_abnormal_impulse_conducting | 0.60248601 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 0.58690122 |
| 80 | MP0002095_abnormal_skin_pigmentation | 0.57813672 |
| 81 | MP0005083_abnormal_biliary_tract | 0.57692063 |
| 82 | MP0000579_abnormal_nail_morphology | 0.56681550 |
| 83 | MP0005503_abnormal_tendon_morphology | 0.54381067 |
| 84 | MP0000003_abnormal_adipose_tissue | 0.52784554 |
| 85 | MP0005248_abnormal_Harderian_gland | 0.52547114 |
| 86 | MP0003959_abnormal_lean_body | 0.51159262 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.49235566 |
| 88 | MP0005452_abnormal_adipose_tissue | 0.49125328 |
| 89 | MP0009672_abnormal_birth_weight | 0.49064714 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.47283454 |
| 91 | MP0000470_abnormal_stomach_morphology | 0.47266796 |
| 92 | MP0008569_lethality_at_weaning | 0.47016712 |
| 93 | MP0003755_abnormal_palate_morphology | 0.46884911 |
| 94 | MP0000343_altered_response_to | 0.46867384 |
| 95 | MP0000266_abnormal_heart_morphology | 0.46428181 |
| 96 | MP0003880_abnormal_central_pattern | 0.46411101 |
| 97 | MP0005423_abnormal_somatic_nervous | 0.45773006 |
| 98 | MP0001243_abnormal_dermal_layer | 0.45437825 |
| 99 | MP0000383_abnormal_hair_follicle | 0.45179812 |
| 100 | MP0003795_abnormal_bone_structure | 0.42362054 |
| 101 | MP0005501_abnormal_skin_physiology | 0.41926968 |
| 102 | MP0005023_abnormal_wound_healing | 0.40918617 |
| 103 | MP0003045_fibrosis | 0.40885570 |
| 104 | MP0004142_abnormal_muscle_tone | 0.40668824 |
| 105 | MP0002127_abnormal_cardiovascular_syste | 0.40115461 |
| 106 | MP0002249_abnormal_larynx_morphology | 0.40055402 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.39382005 |
| 108 | MP0003091_abnormal_cell_migration | 0.39071567 |
| 109 | MP0002168_other_aberrant_phenotype | 0.39049588 |
| 110 | MP0001849_ear_inflammation | 0.37676513 |
| 111 | MP0003879_abnormal_hair_cell | 0.36182661 |
| 112 | MP0008775_abnormal_heart_ventricle | 0.36051870 |
| 113 | MP0002734_abnormal_mechanical_nocicepti | 0.35861793 |
| 114 | MP0009697_abnormal_copulation | 0.35795056 |
| 115 | MP0009703_decreased_birth_body | 0.34781074 |
| 116 | MP0009115_abnormal_fat_cell | 0.33062336 |
| 117 | MP0002114_abnormal_axial_skeleton | 0.33027602 |
| 118 | MP0003948_abnormal_gas_homeostasis | 0.31305915 |
| 119 | MP0000427_abnormal_hair_cycle | 0.31204134 |
| 120 | MP0002060_abnormal_skin_morphology | 0.30925319 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.30699479 |
| 122 | MP0002118_abnormal_lipid_homeostasis | 0.27609068 |
| 123 | MP0010678_abnormal_skin_adnexa | 0.27347588 |
| 124 | MP0003195_calcinosis | 0.27077795 |
| 125 | MP0008438_abnormal_cutaneous_collagen | 0.26926462 |
| 126 | MP0002822_catalepsy | 0.25923791 |
| 127 | MP0005535_abnormal_body_temperature | 0.25177713 |
| 128 | MP0000377_abnormal_hair_follicle | 0.24713174 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.24156615 |
| 130 | MP0005451_abnormal_body_composition | 0.24035613 |
| 131 | MP0009931_abnormal_skin_appearance | 0.23886855 |
| 132 | MP0008770_decreased_survivor_rate | 0.23001817 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.22660006 |
| 134 | MP0001943_abnormal_respiration | 0.22637882 |
| 135 | MP0006138_congestive_heart_failure | 0.22243707 |
| 136 | MP0005076_abnormal_cell_differentiation | 0.19576527 |
| 137 | MP0002932_abnormal_joint_morphology | 0.19338834 |
| 138 | MP0002109_abnormal_limb_morphology | 0.17928089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.30205629 |
| 2 | Exercise-induced myalgia (HP:0003738) | 9.18900362 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.10600652 |
| 4 | Palpebral edema (HP:0100540) | 8.85954756 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 8.52590331 |
| 6 | Nemaline bodies (HP:0003798) | 8.51539015 |
| 7 | Distal arthrogryposis (HP:0005684) | 7.25960684 |
| 8 | Mask-like facies (HP:0000298) | 7.16920631 |
| 9 | Type 1 muscle fiber predominance (HP:0003803) | 6.96944368 |
| 10 | Myopathic facies (HP:0002058) | 6.94228513 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.85882504 |
| 12 | Round ear (HP:0100830) | 6.61120794 |
| 13 | Ulnar deviation of the wrist (HP:0003049) | 6.52470297 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 5.92385535 |
| 15 | Calcaneovalgus deformity (HP:0001848) | 5.64915803 |
| 16 | Difficulty running (HP:0009046) | 5.62819571 |
| 17 | Myoglobinuria (HP:0002913) | 5.57498137 |
| 18 | Deformed tarsal bones (HP:0008119) | 5.33616107 |
| 19 | Absent phalangeal crease (HP:0006109) | 5.26328540 |
| 20 | Muscle fiber splitting (HP:0003555) | 5.11771648 |
| 21 | Muscle stiffness (HP:0003552) | 4.95131031 |
| 22 | Rhabdomyolysis (HP:0003201) | 4.71390602 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 4.69442136 |
| 24 | Increased connective tissue (HP:0009025) | 4.56073360 |
| 25 | Abnormal finger flexion creases (HP:0006143) | 4.40881857 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 4.39644221 |
| 27 | Myotonia (HP:0002486) | 4.26761543 |
| 28 | Periorbital edema (HP:0100539) | 4.13172954 |
| 29 | Facial edema (HP:0000282) | 3.97249009 |
| 30 | Abnormality of the calf musculature (HP:0001430) | 3.84804651 |
| 31 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.84583674 |
| 32 | Malignant hyperthermia (HP:0002047) | 3.74712741 |
| 33 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.60628858 |
| 34 | Subaortic stenosis (HP:0001682) | 3.60628858 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 3.42996517 |
| 36 | Abnormality of the calcaneus (HP:0008364) | 3.42162676 |
| 37 | Difficulty climbing stairs (HP:0003551) | 3.33589786 |
| 38 | Rimmed vacuoles (HP:0003805) | 3.31914371 |
| 39 | Shoulder girdle muscle weakness (HP:0003547) | 3.28679656 |
| 40 | Pelvic girdle muscle weakness (HP:0003749) | 3.28322902 |
| 41 | Hyperkalemia (HP:0002153) | 3.27077159 |
| 42 | Neck muscle weakness (HP:0000467) | 3.26627577 |
| 43 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.17611712 |
| 44 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.17611712 |
| 45 | Frequent falls (HP:0002359) | 3.15801550 |
| 46 | Neoplasm of the heart (HP:0100544) | 3.07940758 |
| 47 | Areflexia of lower limbs (HP:0002522) | 3.05089480 |
| 48 | Paralysis (HP:0003470) | 2.88275523 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.77446973 |
| 50 | Slender build (HP:0001533) | 2.67194932 |
| 51 | Microglossia (HP:0000171) | 2.66918415 |
| 52 | Abnormality of the neuromuscular junction (HP:0003398) | 2.61187741 |
| 53 | Fatigable weakness (HP:0003473) | 2.61187741 |
| 54 | Bell-shaped thorax (HP:0001591) | 2.50196115 |
| 55 | Sudden death (HP:0001699) | 2.44572266 |
| 56 | EMG: neuropathic changes (HP:0003445) | 2.41726918 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 2.40325058 |
| 58 | Hypoalphalipoproteinemia (HP:0003233) | 2.39036823 |
| 59 | Muscular dystrophy (HP:0003560) | 2.37935700 |
| 60 | Hypoplastic ischia (HP:0003175) | 2.25458146 |
| 61 | Limb-girdle muscle weakness (HP:0003325) | 2.25296282 |
| 62 | Nonprogressive disorder (HP:0003680) | 2.23818894 |
| 63 | Down-sloping shoulders (HP:0200021) | 2.20227837 |
| 64 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.16839148 |
| 65 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15350911 |
| 66 | Ulnar deviation of finger (HP:0009465) | 2.14752900 |
| 67 | Metatarsus adductus (HP:0001840) | 2.14367678 |
| 68 | Hyperphosphatemia (HP:0002905) | 2.11180225 |
| 69 | Decreased circulating renin level (HP:0003351) | 2.10691011 |
| 70 | Generalized muscle weakness (HP:0003324) | 2.10474429 |
| 71 | Proximal amyotrophy (HP:0007126) | 2.09988798 |
| 72 | Bulbar palsy (HP:0001283) | 2.05710262 |
| 73 | Spinal rigidity (HP:0003306) | 2.04442892 |
| 74 | Abnormality of the peritoneum (HP:0002585) | 1.99688482 |
| 75 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.97288042 |
| 76 | Abnormality of the ischium (HP:0003174) | 1.97021804 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96151195 |
| 78 | Limb-girdle muscle atrophy (HP:0003797) | 1.93951441 |
| 79 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.93452123 |
| 80 | Rectal prolapse (HP:0002035) | 1.90040353 |
| 81 | Scapular winging (HP:0003691) | 1.88532235 |
| 82 | Achilles tendon contracture (HP:0001771) | 1.87872426 |
| 83 | Facial diplegia (HP:0001349) | 1.86001546 |
| 84 | Tarsal synostosis (HP:0008368) | 1.85773178 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 1.84309401 |
| 86 | Lip pit (HP:0100267) | 1.83221994 |
| 87 | Stridor (HP:0010307) | 1.82266035 |
| 88 | Gowers sign (HP:0003391) | 1.79700498 |
| 89 | Weak cry (HP:0001612) | 1.76176158 |
| 90 | Hyperuricemia (HP:0002149) | 1.75108252 |
| 91 | Increased purine levels (HP:0004368) | 1.75108252 |
| 92 | Hypolipoproteinemia (HP:0010981) | 1.74048188 |
| 93 | Ventricular tachycardia (HP:0004756) | 1.71563630 |
| 94 | Abnormality of the Achilles tendon (HP:0005109) | 1.71494330 |
| 95 | Gout (HP:0001997) | 1.71370192 |
| 96 | Waddling gait (HP:0002515) | 1.70737311 |
| 97 | Increased density of long bones (HP:0006392) | 1.70228206 |
| 98 | Abnormality of potassium homeostasis (HP:0011042) | 1.69416686 |
| 99 | Cholelithiasis (HP:0001081) | 1.69136065 |
| 100 | Short palpebral fissure (HP:0012745) | 1.68625119 |
| 101 | Spontaneous abortion (HP:0005268) | 1.68470208 |
| 102 | Complement deficiency (HP:0004431) | 1.68089020 |
| 103 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.67232819 |
| 104 | Synostosis involving bones of the feet (HP:0009140) | 1.67174782 |
| 105 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.67174782 |
| 106 | Abnormality of chloride homeostasis (HP:0011422) | 1.66868771 |
| 107 | Glomerulonephritis (HP:0000099) | 1.64928562 |
| 108 | Progressive muscle weakness (HP:0003323) | 1.61996121 |
| 109 | Oligomenorrhea (HP:0000876) | 1.59735689 |
| 110 | Hypoplastic iliac wings (HP:0002866) | 1.55592034 |
| 111 | Mesomelia (HP:0003027) | 1.54779106 |
| 112 | Fetal akinesia sequence (HP:0001989) | 1.54160676 |
| 113 | Supernumerary ribs (HP:0005815) | 1.51604798 |
| 114 | Atrioventricular block (HP:0001678) | 1.51312568 |
| 115 | Fibular aplasia (HP:0002990) | 1.49909944 |
| 116 | Abnormal gallbladder morphology (HP:0012437) | 1.49759496 |
| 117 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.49677700 |
| 118 | Adducted thumb (HP:0001181) | 1.49634491 |
| 119 | Menstrual irregularities (HP:0000858) | 1.49459061 |
| 120 | Abnormality of the columella (HP:0009929) | 1.48638214 |
| 121 | Congenital hip dislocation (HP:0001374) | 1.46498884 |
| 122 | Hypokalemia (HP:0002900) | 1.44856718 |
| 123 | Long clavicles (HP:0000890) | 1.41760471 |
| 124 | Abnormality of purine metabolism (HP:0004352) | 1.41248670 |
| 125 | Toxemia of pregnancy (HP:0100603) | 1.41233974 |
| 126 | Intellectual disability, moderate (HP:0002342) | 1.39974908 |
| 127 | Heart block (HP:0012722) | 1.39798997 |
| 128 | Macroorchidism (HP:0000053) | 1.39683471 |
| 129 | Wrist flexion contracture (HP:0001239) | 1.39222240 |
| 130 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.38854220 |
| 131 | Exercise intolerance (HP:0003546) | 1.38085053 |
| 132 | Broad metatarsal (HP:0001783) | 1.35360363 |
| 133 | Abnormality of the parietal bone (HP:0002696) | 1.34182355 |
| 134 | Abnormal atrioventricular conduction (HP:0005150) | 1.32293264 |
| 135 | Decreased subcutaneous fat (HP:0001002) | 1.31981200 |
| 136 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.31971756 |
| 137 | Hip contracture (HP:0003273) | 1.31304236 |
| 138 | Metabolic acidosis (HP:0001942) | 1.31043983 |
| 139 | Overgrowth (HP:0001548) | 1.30406841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.94589606 |
| 2 | TTN | 6.52554614 |
| 3 | PHKG2 | 6.43488852 |
| 4 | PHKG1 | 6.43488852 |
| 5 | NME1 | 4.61888144 |
| 6 | PIK3CG | 3.52311620 |
| 7 | MAP2K3 | 3.03253884 |
| 8 | TYRO3 | 2.73270925 |
| 9 | WNK4 | 2.58182642 |
| 10 | WNK1 | 2.51372847 |
| 11 | NEK1 | 2.40387551 |
| 12 | MAP3K7 | 2.22844557 |
| 13 | JAK3 | 2.18256887 |
| 14 | PINK1 | 2.07158882 |
| 15 | IRAK1 | 1.95850508 |
| 16 | PIK3CA | 1.93819353 |
| 17 | CAMKK2 | 1.87440984 |
| 18 | PDK3 | 1.83344436 |
| 19 | PDK4 | 1.83344436 |
| 20 | MAP2K4 | 1.83100263 |
| 21 | MAPK13 | 1.83072602 |
| 22 | TRIB3 | 1.82891784 |
| 23 | CASK | 1.74694273 |
| 24 | MAPK12 | 1.68292009 |
| 25 | BCKDK | 1.64890517 |
| 26 | MAP2K6 | 1.56483968 |
| 27 | DMPK | 1.55583485 |
| 28 | CDK4 | 1.44695281 |
| 29 | PDK2 | 1.22504651 |
| 30 | CHEK2 | 1.21539977 |
| 31 | CCNB1 | 1.10243047 |
| 32 | FGFR3 | 1.09975727 |
| 33 | PRKAA2 | 1.01695262 |
| 34 | NEK9 | 0.94006593 |
| 35 | PRKAA1 | 0.91239149 |
| 36 | AURKA | 0.90111950 |
| 37 | MAPKAPK3 | 0.89931235 |
| 38 | MAP3K3 | 0.88895140 |
| 39 | MUSK | 0.86834840 |
| 40 | CAMK4 | 0.82477142 |
| 41 | SGK2 | 0.82123704 |
| 42 | ERBB3 | 0.80840505 |
| 43 | TAOK2 | 0.79117115 |
| 44 | MARK3 | 0.78213514 |
| 45 | TRPM7 | 0.76558523 |
| 46 | MAP3K9 | 0.75973334 |
| 47 | STK24 | 0.75734351 |
| 48 | SCYL2 | 0.74526866 |
| 49 | MARK2 | 0.65144747 |
| 50 | SIK1 | 0.63625978 |
| 51 | MAPK11 | 0.61696747 |
| 52 | PRKD2 | 0.61386747 |
| 53 | CAMK1 | 0.60780651 |
| 54 | MAP3K11 | 0.60592206 |
| 55 | TAOK1 | 0.60095968 |
| 56 | MAP3K12 | 0.59108879 |
| 57 | CAMK2G | 0.58970390 |
| 58 | CAMKK1 | 0.58680070 |
| 59 | STK39 | 0.58330332 |
| 60 | RIPK1 | 0.58126114 |
| 61 | PDGFRA | 0.57624608 |
| 62 | NLK | 0.56389089 |
| 63 | EPHB1 | 0.53650771 |
| 64 | STK38 | 0.53293288 |
| 65 | PKN2 | 0.51853901 |
| 66 | FGFR2 | 0.51436238 |
| 67 | SGK223 | 0.48752129 |
| 68 | SGK494 | 0.48752129 |
| 69 | DAPK2 | 0.47050031 |
| 70 | ZAK | 0.47029498 |
| 71 | AKT2 | 0.46805638 |
| 72 | EEF2K | 0.44266901 |
| 73 | PTK6 | 0.43943585 |
| 74 | MAP3K6 | 0.40377112 |
| 75 | KSR2 | 0.39536285 |
| 76 | ILK | 0.37550401 |
| 77 | SGK1 | 0.35614721 |
| 78 | TEC | 0.35483485 |
| 79 | MAP3K1 | 0.33475266 |
| 80 | NUAK1 | 0.32724839 |
| 81 | DYRK3 | 0.32358431 |
| 82 | LIMK1 | 0.31406986 |
| 83 | CAMK1G | 0.29476207 |
| 84 | PRKACB | 0.28460179 |
| 85 | RPS6KA3 | 0.27594256 |
| 86 | MAP3K5 | 0.27409734 |
| 87 | PRKG1 | 0.26730773 |
| 88 | PKN1 | 0.26581700 |
| 89 | MAP3K10 | 0.25953380 |
| 90 | RPS6KB1 | 0.24193141 |
| 91 | ARAF | 0.23557205 |
| 92 | MAPK7 | 0.22303806 |
| 93 | PDGFRB | 0.21660997 |
| 94 | ERN1 | 0.21094095 |
| 95 | MAPK4 | 0.20797650 |
| 96 | PRKACA | 0.19807595 |
| 97 | TYK2 | 0.19550441 |
| 98 | EIF2AK2 | 0.19084487 |
| 99 | TNIK | 0.18608040 |
| 100 | RAF1 | 0.18430810 |
| 101 | PAK6 | 0.17779980 |
| 102 | LATS1 | 0.17460497 |
| 103 | MAP2K1 | 0.16649069 |
| 104 | MST1R | 0.16506586 |
| 105 | PDPK1 | 0.15328454 |
| 106 | PRKD1 | 0.15187637 |
| 107 | CSNK1G1 | 0.15080310 |
| 108 | FRK | 0.14052444 |
| 109 | PRKD3 | 0.13913720 |
| 110 | LATS2 | 0.13788024 |
| 111 | AKT3 | 0.13322850 |
| 112 | PRKG2 | 0.12547553 |
| 113 | GSK3B | 0.12433899 |
| 114 | PDK1 | 0.12066945 |
| 115 | DYRK1B | 0.12008214 |
| 116 | ROCK1 | 0.11144313 |
| 117 | TIE1 | 0.10932927 |
| 118 | DDR2 | 0.10842735 |
| 119 | FER | 0.10697892 |
| 120 | TGFBR2 | 0.10277406 |
| 121 | FGFR1 | 0.10116397 |
| 122 | RPS6KA1 | 0.10083424 |
| 123 | LRRK2 | 0.09313414 |
| 124 | BMX | 0.09111012 |
| 125 | INSRR | 0.08978593 |
| 126 | MOS | 0.06858222 |
| 127 | PRKACG | 0.06723713 |
| 128 | JAK2 | 0.05957586 |
| 129 | STK11 | 0.05769262 |
| 130 | GSK3A | 0.05366930 |
| 131 | ICK | 0.05077585 |
| 132 | MAPK10 | 0.04316379 |
| 133 | KSR1 | 0.04196800 |
| 134 | MTOR | 0.04156439 |
| 135 | SGK3 | 0.02836670 |
| 136 | MAPK8 | 0.02553786 |
| 137 | CSNK1D | 0.02376870 |
| 138 | CAMK2D | 0.01616888 |
| 139 | RPS6KA2 | 0.01224541 |
| 140 | PNCK | 0.01139511 |
| 141 | PTK2B | 0.00798571 |
| 142 | RET | -0.0058570 |
| 143 | CAMK1D | -0.0046763 |
| 144 | MAPK9 | -0.0039063 |
| 145 | RPS6KB2 | -0.0034246 |
| 146 | MAP3K4 | -0.0033529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.11915478 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.90016728 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.77930529 |
| 4 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.26680606 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.25402256 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.17507659 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.09322777 |
| 8 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.97099909 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.62932368 |
| 10 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.58753691 |
| 11 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.45225820 |
| 12 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.45033207 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.28121845 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 2.27497145 |
| 15 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.25245627 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.19759880 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.17332985 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 2.14054914 |
| 19 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.95434139 |
| 20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.94711962 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92994452 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.89562155 |
| 23 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.84215489 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.73727154 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70461007 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67311573 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60037973 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55950496 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49628744 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45105902 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.42288406 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40814436 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40362164 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.39480738 |
| 35 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.38345279 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.38339377 |
| 37 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.37125233 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.34206843 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.30996921 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27517891 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.22906652 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.22034168 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21566378 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19755213 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.17597181 |
| 46 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.17016205 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13247845 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13219675 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.11915827 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.11718247 |
| 51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.11162610 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.09686846 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 1.05409962 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03216164 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99524697 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98401938 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.97729026 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.97332448 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91651501 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.91203681 |
| 61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90409179 |
| 62 | * Tight junction_Homo sapiens_hsa04530 | 0.88100886 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87445194 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86100329 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85375890 |
| 66 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.85102184 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80157459 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 0.78347604 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76948516 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76536618 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75765067 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71729612 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71457767 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.70618875 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67988589 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.67975616 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67948722 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67884810 |
| 79 | Morphine addiction_Homo sapiens_hsa05032 | 0.65769160 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65127117 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63003735 |
| 82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.62454163 |
| 83 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.62453559 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.61628648 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61524618 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61129153 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57949626 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57522049 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55366929 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54451520 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50498178 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50297591 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50009694 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48677241 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.48051394 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47997936 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47912306 |
| 98 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46068795 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.45218739 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.44684539 |
| 101 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43582575 |
| 102 | Long-term depression_Homo sapiens_hsa04730 | 0.43428735 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.43316518 |
| 104 | Axon guidance_Homo sapiens_hsa04360 | 0.43064287 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42491536 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42234217 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39653506 |
| 108 | Melanoma_Homo sapiens_hsa05218 | 0.37677684 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37624908 |
| 110 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36039262 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35172516 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33175528 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32502296 |
| 114 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31327067 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29377927 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27872226 |
| 117 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.23916467 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21836402 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21412664 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.20993274 |
| 121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.20375001 |
| 122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.20086844 |
| 123 | Long-term potentiation_Homo sapiens_hsa04720 | 0.19692742 |
| 124 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.19584715 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18646647 |
| 126 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.17328394 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17248470 |
| 128 | Circadian entrainment_Homo sapiens_hsa04713 | 0.15831395 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15291760 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.13600543 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13563592 |
| 132 | Melanogenesis_Homo sapiens_hsa04916 | 0.13549564 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.11930902 |
| 134 | ABC transporters_Homo sapiens_hsa02010 | 0.11307938 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.10656349 |
| 136 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.09557614 |
| 137 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.07503943 |
| 138 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.07261020 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.07230596 |
| 140 | Sulfur relay system_Homo sapiens_hsa04122 | 0.07011977 |
| 141 | Thyroid cancer_Homo sapiens_hsa05216 | 0.06311022 |
| 142 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.06136148 |
| 143 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.05691904 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.03641022 |
| 145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.03486933 |

